Systemic sclerosis in 2014: Advances in cohort enrichment shape future of trial design

Yannick Allanore1, Oliver Distler2

  • 1Department of Rheumatology A, Medicine Faculty, Paris Descartes University, 27 Rue du Faubourg Saint Jacques, Cochin Hospital, 75014 Paris, France.

Insights

Systemic sclerosis (SSc) treatment is advancing with new clinical trials. Future research should refine patient selection for targeted therapies, improving SSc management.

Area of Science:

  • Rheumatology
  • Immunology
  • Clinical Trials

Background:

  • Systemic sclerosis (SSc) pathogenesis understanding has improved.
  • Several randomized controlled trials (RCTs) in SSc are emerging.
  • Previous trial designs from 2014 require further development.

Purpose of the Study:

  • To highlight the evolving landscape of systemic sclerosis treatment.
  • To emphasize the need for enhanced patient stratification in SSc clinical trials.
  • To advocate for precision medicine approaches in SSc therapy.

Main Methods:

  • Review of recent advancements in SSc clinical trial design.
  • Analysis of the impact of improved SSc pathogenesis knowledge.
  • Discussion on strategies for optimizing patient selection in SSc studies.

Main Results:

  • The field of SSc treatment is undergoing significant transformation.
  • Current trial designs are based on a better grasp of SSc.
  • There is a clear need for improved patient subgroup identification.

Conclusions:

  • Systemic sclerosis research is entering a new era of therapeutic development.
  • Building upon 2014 trial design advancements is crucial.
  • Enhanced patient selection will enable targeted SSc therapies for specific subgroups.

Related Concept Videos

Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.6K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.2K
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
2
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
856
Study Design in Statistics01:15

Study Design in Statistics

A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
10.4K